Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Effect of Crestor on Lipoprotein Metabolism in Humans

This study has been completed.
Sponsor:
Collaborator:
AstraZeneca
Information provided by:
Atlanta Research and Education Foundation
ClinicalTrials.gov Identifier:
NCT00214617
First received: September 19, 2005
Last updated: September 22, 2006
Last verified: September 2006
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: February 2006
  Estimated Primary Completion Date: No date given